Mangalam Drugs

{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "33.91",
    "chg": -0.66,
    "chgp": "-1.91%",
    "dir": -1,
    "prev_price": "34.57",
    "mcapval": "53.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE584F01014",
    "curr_date": "Feb 12",
    "curr_time": "",
    "bse_nse_vol": "1.02 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 12, 2026",
    "traded_date_str": "2026 02 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs Declines 2.07%: 5 Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-declines-207-5-key-events-shaping-the-week-3827532",
        "imagepath": "",
        "date": "2026-02-08 16:01:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Lower circuit hit amid heavy selling at Rs.32.68</p>\n                    <p><strong>3 Feb:</strong> Upper circuit triggered with strong buying at Rs.37.90</p>\n                    <p><strong>4 Feb:</strong> Lower circuit hit again closing at Rs.36.01</p>\n                    <p><strong>5 Feb:</strong> Consecutive lower circuit close at Rs.34.21</p>\n                    <p><strong>6 Feb:</strong> Week ends with lower circuit at Rs.32.50</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.36.29</div></div>\n                    <div class=\"stat-item..."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3823888",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3823888.png",
        "date": "2026-02-06 10:00:12",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 6 Feb 2026, closing at ₹32.5, down 5.0% on the day. The stock faced intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and unfilled supply. This marks the third consecutive day of declines, with the stock losing over 14% in that period, significantly underperforming its sector and the broader market."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3822243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_mojoScore_3822243.png",
        "date": "2026-02-05 10:10:38",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 February 2026, providing investors with the latest insights into the stock’s performance and outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3822042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3822042.png",
        "date": "2026-02-05 10:00:12",
        "description": "Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 5 Feb 2026, hitting its lower circuit price limit of ₹34.21. The stock closed with a maximum daily loss of 5.0%, reflecting intense selling pressure and panic among investors amid subdued market sentiment and deteriorating technical indicators."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3820114",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3820114.png",
        "date": "2026-02-04 10:00:10",
        "description": "Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 4 February 2026, closing at ₹36.01, down 4.99% on the day. The stock faced intense selling pressure, with volumes surging and the price hitting the maximum permissible daily loss, reflecting mounting investor concerns amid a deteriorating outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-robust-buying-pressure-3818011",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_upper_circuit_3818011.png",
        "date": "2026-02-03 10:00:24",
        "description": "Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 3 February 2026, propelled by robust buying interest and significant investor participation. The stock closed at ₹37.90, marking a 4.99% gain on the day, outperforming its sector and the broader market indices."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3816005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3816005.png",
        "date": "2026-02-02 10:00:06",
        "description": "Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 2 Feb 2026, hitting its lower circuit price limit of ₹32.68. The stock endured intense selling pressure, culminating in a maximum daily loss of 4.97%, marking its ninth consecutive day of decline and signalling mounting investor panic amid deteriorating fundamentals."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3814370",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MangalamDrugsan_stocks_hitting_lower_circuit_3814370.png",
        "date": "2026-02-01 11:00:08",
        "description": "Mangalam Drugs and Organics Ltd witnessed a sharp decline on 1 Feb 2026, hitting its lower circuit limit of 5%, closing at ₹34.39. The stock faced intense selling pressure, marking its eighth consecutive day of losses and underperforming the Pharmaceuticals & Biotechnology sector by over 5% today."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3810870",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MangalamDrugsan_stocks_hitting_lower_circuit_3810870.png",
        "date": "2026-01-30 10:00:09",
        "description": "Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 30 Jan 2026, hitting its lower circuit price limit of ₹36.20. The stock endured intense selling pressure, closing with a maximum daily loss of 4.99%, marking its seventh consecutive day of decline and signalling heightened investor anxiety."
      }
    ],
    "total": 171,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "details": "Mangalam Drugs And Organics Limitedalam Drugs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Reply to Clarification- Financial results",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limitedgs And Organics Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Clarification - Financial Results",
      "datetime": "21-Nov-2019"
    },
    {
      "details": "Mangalam Drugs And Organics Limited has informed the Exchange regarding Compliance under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Mangalam Drugs And Organics Limited - Other General Purpose",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs Declines 2.07%: 5 Key Events Shaping the Week

2026-02-08 16:01:16

Key Events This Week

2 Feb: Lower circuit hit amid heavy selling at Rs.32.68

3 Feb: Upper circuit triggered with strong buying at Rs.37.90

4 Feb: Lower circuit hit again closing at Rs.36.01

5 Feb: Consecutive lower circuit close at Rs.34.21

6 Feb: Week ends with lower circuit at Rs.32.50

Week Open

Rs.36.29

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-06 10:00:12

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 6 Feb 2026, closing at ₹32.5, down 5.0% on the day. The stock faced intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and unfilled supply. This marks the third consecutive day of declines, with the stock losing over 14% in that period, significantly underperforming its sector and the broader market.

Read full news article

Mangalam Drugs and Organics Ltd is Rated Strong Sell

2026-02-05 10:10:38

Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 February 2026, providing investors with the latest insights into the stock’s performance and outlook.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-05 10:00:12

Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 5 Feb 2026, hitting its lower circuit price limit of ₹34.21. The stock closed with a maximum daily loss of 5.0%, reflecting intense selling pressure and panic among investors amid subdued market sentiment and deteriorating technical indicators.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-04 10:00:10

Shares of Mangalam Drugs and Organics Ltd plunged to their lower circuit limit on 4 February 2026, closing at ₹36.01, down 4.99% on the day. The stock faced intense selling pressure, with volumes surging and the price hitting the maximum permissible daily loss, reflecting mounting investor concerns amid a deteriorating outlook.

Read full news article

Mangalam Drugs and Organics Ltd Hits Upper Circuit Amid Robust Buying Pressure

2026-02-03 10:00:24

Mangalam Drugs and Organics Ltd surged to its upper circuit limit on 3 February 2026, propelled by robust buying interest and significant investor participation. The stock closed at ₹37.90, marking a 4.99% gain on the day, outperforming its sector and the broader market indices.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-02 10:00:06

Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 2 Feb 2026, hitting its lower circuit price limit of ₹32.68. The stock endured intense selling pressure, culminating in a maximum daily loss of 4.97%, marking its ninth consecutive day of decline and signalling mounting investor panic amid deteriorating fundamentals.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-01 11:00:08

Mangalam Drugs and Organics Ltd witnessed a sharp decline on 1 Feb 2026, hitting its lower circuit limit of 5%, closing at ₹34.39. The stock faced intense selling pressure, marking its eighth consecutive day of losses and underperforming the Pharmaceuticals & Biotechnology sector by over 5% today.

Read full news article

Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-01-30 10:00:09

Mangalam Drugs and Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 30 Jan 2026, hitting its lower circuit price limit of ₹36.20. The stock endured intense selling pressure, closing with a maximum daily loss of 4.99%, marking its seventh consecutive day of decline and signalling heightened investor anxiety.

Read full news article

View All News